Research Project

Project Title:	Post-Marketing Surveillance Study of Tolvaptan in Patients With ADPKD
Project Type:	Observational Study, Enrolment ongoing
Disease group(s):	Congenital Malformations & Ciliopathies
Project Summary:	The purpose of this study is to evaluate the safety and effectiveness of tolvaptan in patients with autosomal dominant polycystic kidney disease (ADPKD) in the real world clinical setting in Japan.
Lead principal investigator(s):	Bertrand Knebelmann, Paris
Project Period:	03/2014 - 03/2023
Sponsors:	Industry
ClinicalTrials.gov:	NCT02847624